Will expand patient access to breakthrough BPH treatment
San Francisco, CA (UroToday.com) — Teleflex Incorporated announced that the company has received reimbursement approval from the Central Social Insurance Medical Council of Japan (Chuikyo) of its UroLift System for patients who require treatment for benign prostatic hyperplasia (BPH).